Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas

Journal of Cellular Biochemistry

Volumn 62, Issue 4, 1996, Pages 443-453

  Uchiyama, Akihiko ^a   Essner, Richard ^a   Doi, Fukashi ^a   Nguyen, Tung ^a   Ramming, Kenneth P ^a   Nakamura, Toshikazu ^b   Morton, Donald L ^a   Hoon, Dave S B ^a,c  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c John Wayne Inst Cancer Treatm Res   (United States)

Author keywords

cancer; collagenase; cytokine; Met; metastasis; motility

Indexed keywords

COLLAGENASE; GELATINASE; GELATINASE B; GROWTH FACTOR RECEPTOR; INTERLEUKIN 4 RECEPTOR; RECOMBINANT INTERLEUKIN 4; SCATTER FACTOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL;

ANTIGENS, CD; CELL DIVISION; CELL MOVEMENT; COLLAGENASES; COLONIC NEOPLASMS; ELECTROPHORESIS, AGAR GEL; GLYCOPROTEINS; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-4; MATRIX METALLOPROTEINASE 9; PROTEINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-4; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED;

EID: 0029763184     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960915)62:4<443::AID-JCB2>3.0.CO;2-M     Document Type: Article

References (48)

1. Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, Von Eschenbach A, Itoh K (1990): Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 125:200-205.
2. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991): Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804.
3. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM (1992): Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119:629-641.
4. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992): Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701-708.
5. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM (1991): Expression of the Met/HGF receptor in normal and neoplastic tissues. Oncogene 6:1997-2003.
6. Fridman R, Toth M, Rena D, Mobashery S (1995): Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555.
7. Giordano S, Zhen Z, Medico E, Gaudino G, Galimi F, Comoglio PM (1993): Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc Natl Acad Sci USA 90:649-653.
8. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y (1988): Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81:414-419.
9. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR (1991): Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 49:666-672.
10. Hoon DSB, Banez M, Okun E, Morton DL, Irie RF (1991a): Modulation of human melanoma cells by interleukin-4 and in combination with γ-interferon or α-tumor necrosis factor. Cancer Res 51:2002-2008.
11. Hoon DSB, Okun E, Banez M, Irie FR, Morton DL (1991b): Interleukin 4 alone and with gamma-interferon or α-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas. Cancer Res 51:5687-5693.
12. Hoon DSB, Hayashi Y, Morisaki T, Foshag LJ, Morton DL (1993): Interleukin-4 plus tumor necrosis factor α augments the antigenicity of melanoma cells. Cancer Immunol Immunother 37:378-384.
13. Hoon DSB, Morisaki T, Essner R (1996): Interleukin-4 and related cytokines inhibition of non-hemopoietic cancer cell growth. In Dagleish A, Browning M (eds): "Tumor Immunology." London: Cambridge University Press (in press).
14. Jiang WG, Hallet MB, Puntis MC (1993): Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 80:1368-1373.
15. Kaklamanis L, Gatter KC, Mortensen N, Harris AL (1992): Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer. Br J Cancer 66:712-716.
16. Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, Kubo M, MukudaT, Fusamoto H, Kamada T (1992): Changes in serum human hepatocyte growth factor levels after trans-catheter arterial embolization and partial hepatectomy. Am J Gastroenterol 87:1014-1017.
17. Kenworthy P, Dowrick P, Baillie-Johnson H, McCann B, Tsubouchi H, Arakaki N, Daikuhara Y, Warn RM (1992): The presence of scatter factor in patients with metastatic spread to the pleura. Br J Cancer 66:243-247.
18. Konishi T, Takehara T, Tsuji T, Ohsato K, Matsumoto K, Nakamura T (1991): Scatter factor from human embryonic lung flbroblasts is probably identical to hepatocyte growth factor. Biochem Biophys Res Commun 180:765-773.
19. Lacraz S, Nicod L, Galvede Rochemonteix B, Baumberger C, Dayer JM, Welgus HG (1992): Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 90:382-388.
20. Liabakk N-B, Talbot I, Smith RA, Wilkinson K, Balkwill F (1996): Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56:190-196.
21. Liotta LA and Stetler-Stevenson WG (1991): Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res Suppl 51:5045s-5059s.
22. Mareel MM, Baetselier PD, Van Roy FM (1991): Bioassays for invasion and metastasis. In: Mareel MM, Baetselier PD, Van Roy FM (eds): "Mechanisms of Invasion and Metastasis." Florida: CRC Press Inc, pp 41-51.
23. Matrisian LM (1990): Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125.
24. Matsumoto K, Hashimoto K, Yoshikawa K, Nakamura T (1991): Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 196:114-120.
25. Matsumoto K, Okazaki H, Nakamura T (1992): Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 188:235-243.
26. Matsumoto K, Nakamura T (1993): Roles of HGF as a pleiotropic factor in organ regeneration. In: Goldberg ID, Rosen EM (eds): "Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-Met Receptor." Basel, Switzerland: Birkhauser Verlag, pp 225-249.
27. Montesano R, Matsumoto K, Nakamura T, Orci L (1991): Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908.
28. Morisaki T, Yuzuki DH, Lin RT, Foshag LJ, Morton DL, Hoon DS (1992): Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4. Cancer Res 52:6059-6065.
29. 1 cell cycle progression in gastric carcinoma cells. Cancer Res 54:1113-1118.
30. Nakajima M, Welch DR, Belloni PN, Nicolson GL (1987): Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47:4869-4876.
31. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S (1989): Molecular cloning and expression of human hepatocyte growth factor. Nature (London) 342:440-443.
32. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM (1991): Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene 6:501-504.
33. Nicolson GL (1982): Cancer metastasis: Organ colonization and cell surface properties of malignant cells. Biochem Biophys Acta 695:113-176.
34. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T (1990): Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 173:42-47.
35. Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK (1993): Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest 91:88-93.
36. Paul WE, Ohara J (1987): B-cell stimulating factor-interleukin 4. Annu Rev Immunol 5:429-459.
37. Rosen EM, Meromsky L, Goldberg I, Bhargava M, Setter E (1990): Studies on the mechanism of scatter factor. Effects of agents that modulate intracellular signal transduction, macromolecule synthesis and cytoskeleton assembly. J Cell Sci 96:639-649.
38. Seslar SP, Nakamura T, Byers SW (1993): Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 53:1233-1238.
39. Stoker M, Gherardi E, Perryman M, Gray J (1987): Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:239-242.
40. Tajima H, Matsumoto K, Nakamura T (1992): Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202:423-431.
41. Tetlow LC, Lees M, Ogata Y, Nagase H, Woolle DE (1993): Differential expression gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 13:53-59.
42. Tempest PR, Stratton MR, Cooper CS (1988): Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br J Cancer 58:3-7.
43. Toi M, Bicknell R, Harris AL (1992): Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52:275-279.
44. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF (1992): The met proto-oncogene receptor and lumen formation. Science 257:1258-1261.
45. Tungekar MF, Turley H, Dunnill MS, Gatter KC, Ritter MA, Harris AL (1991): Interleukin 4 receptor expression on human lung tumors and normal lung. Cancer Res 51:261-264.
46. Uchiyama A, Kitsuki H, Shimura H, Torisu M (1992): Suppression by interferon-γ of tumor cell-induced increase in mesothelial permeability. Clin Exp Metastasis 10:371-378.
47. Van der Stappen JW, Hendriks T, Wobbes T (1990): Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 45:1071-1078.
48. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W (1990): Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111:2097-2108.